Needles, Syringes, IV Access Market Research Reports & Industry Analysis
This issue has placed a premium on the development of new products designed to prevent accidental needle sticks, which spread blood-borne pathogens.
Medical supply manufacturers around the globe are trying to develop new safety and innovative products, including sharps safety medical devices to protect health care workers. The University of Virginia’s International Healthcare Worker Safety Center lists 12 companies offering retractable needles/syringes.
The products involve a variety of technologies, for example, a safety needle device has a needle encapsulation sleeve after it has been used; the sleeve automatically resheathes the needle and locks it so that it cannot be exposed.
Blunt safety devices deploy a two-needle system, one inside the other. The inside needle is hollow and has a flat, blunt end. The outside sharp needle is used to access the vein. The inner needle moves forward and past the sharp needle to insure safety before it is removed from the patient. Such devices are known as first-generation safety products.
The retractable syringe is a unique device requiring no change in the basic procedure of delivery of the medication by health care workers. Once the injection is complete, the needle safely retracts from the patient into the syringe barrel -- thus, there is no risk of accidental needle stick injuries that can transmit HIV, hepatitis, or other infections to health care workers. Retractable syringes are considered second generation safety products.
Needles, Syringes, IV Access Industry Research & Market Reports
-
Dental Syringes
... CAGR of 6.2% over the analysis period 2024-2030. Non-Disposable Syringes, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$99.6 Million by the end of the analysis ... Read More
-
Disinfection Caps
... CAGR of 4.2% over the analysis period 2024-2030. Non-Retail Distributor, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$289.3 Million by the end of the analysis ... Read More
-
Retractable Needle Safety Syringes
... 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Automatic Retractable Needle Safety Syringes, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$176.7 ... Read More
-
Sterile Injectable Drugs
... at a CAGR of 9.7% over the analysis period 2024-2030. Small Molecule Drugs, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$577.6 Billion by the end ... Read More
-
Intravenous Needles
... CAGR of 6.3% over the analysis period 2024-2030. Teflon Dispensing Needles, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$1.8 Billion by the end of the ... Read More
-
Disposable Syringes
... CAGR of 6.1% over the analysis period 2024-2030. Safety Syringes, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$15.0 Billion by the end of the analysis ... Read More
-
Acute Care Needleless Connectors
... 2030, growing at a CAGR of 9.1% over the analysis period 2024-2030. Simple Needleless Connectors, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$1.2 Billion by ... Read More
-
Biopsy Needles
... CAGR of 5.7% over the analysis period 2024-2030. Vacuum-Assisted Needles, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$971.8 Million by the end of the analysis ... Read More
-
Insulin Pen Needles
... at a CAGR of 6.7% over the analysis period 2024-2030. Standard Insulin Pen Needles, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.7 Billion by the ... Read More
-
The U.S. Medical Weight Loss Market: The Impact of GLP-1s On Doctors, Hospitals, Clinics and Franchises
... There are no medical associations or private sector research firms that cover the small and privately-owned medical weight loss chains, franchises, hospitals and clinics. Marketdata has filled in the gaps with extensive primary research. The ... Read More
-
Special Purpose Needles
... at a CAGR of 6.7% over the analysis period 2024-2030. Hypodermic Needles, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$6.9 Billion by the end of ... Read More
-
Sharps Containers
... CAGR of 5.7% over the analysis period 2024-2030. Multipurpose Containers, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$352.8 Million by the end of the analysis ... Read More
-
Iron Drugs
... CAGR of 7.9% over the analysis period 2024-2030. Oral Drugs, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$6.7 Billion by the end of the analysis ... Read More
-
Needles
... 4.9% over the analysis period 2024-2030. Conventional Needles, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$6.6 Billion by the end of the analysis period. Growth ... Read More
-
Aspiration & Biopsy Needles
... 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Biopsy Needles, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.0 Billion by the ... Read More
-
Intravenous (IV) Solutions
... at a CAGR of 7.5% over the analysis period 2024-2030. Parenteral Nutrition, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$15.1 Billion by the end of ... Read More
-
Amniocentesis Needles
... CAGR of 2.1% over the analysis period 2024-2030. 150 mm & Above Needles, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$67.3 Million by the end ... Read More
-
Wearable Injectors
... CAGR of 9.5% over the analysis period 2024-2030. On-Body Injectors, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$14.7 Billion by the end of the analysis ... Read More
-
Infusion Pumps
... CAGR of 4.7% over the analysis period 2024-2030. Volumetric Infusion Pumps, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$2.2 Billion by the end of the ... Read More
-
Endoscopic Ultrasound Needles
... at a CAGR of 2.7% over the analysis period 2024-2030. Aspiration Needles (EUS-FNA), one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$150.5 Million by the end ... Read More
-
Injectable Drugs Delivery
... at a CAGR of 10.1% over the analysis period 2024-2030. Injectable Drugs Delivery Devices, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$1.4 Trillion by the ... Read More
-
Enteral Syringes
... CAGR of 5.6% over the analysis period 2024-2030. Disposable Syringes, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$1.5 Billion by the end of the analysis ... Read More
-
Pipette Tips
... CAGR of 5.1% over the analysis period 2024-2030. Manual Pipette Tips, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$748.2 Million by the end of the ... Read More
-
Huber Needles
... CAGR of 4.8% over the analysis period 2024-2030. Curved Display Needles, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$77.6 Million by the end of the ... Read More
-
Venipuncture Procedure
... CAGR of 4.4% over the analysis period 2024-2030. Median Cubital Vein, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$776.5 Million by the end of the ... Read More
Research Assistance
